Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating radiation therapy plus gadolinium texaphyrin (motexafin gadolinium) in patients with unresectable pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer [Phase 1]
Phase 1 trial of denileukin diftitox followed by vaccine therapy in patients with metastatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 1]
This document summarizes the completed Phase I trial evaluating the combination of capecitabine, gemcitabine, and erlotinib in patients with…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer [Phase 1]
This document reports the completion of the Phase 1 portion of a Phase I/II trial evaluating intratumoral dendritic cell immunotherapy in co…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating apricoxib with gemcitabine and erlotinib for advanced pancreatic cancer; the study is completed and results were po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer [Phase 3]
Phase III trial comparing Gemcitabine, TS-1, and Gemcitabine plus TS-1 in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating aprepitant to prevent nausea and vomiting in patients undergoing chemotherapy and radiation therapy for pancreatic …
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy [Phase 4]
Phase 4 clinical trial update on preoperative immunonutrition for patients undergoing pancreaticoduodenectomy; the study is reported as comp…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study [Phase 4]
Phase 4 pilot study evaluating endoscopic ultrasound-guided celiac plexus neurolysis with absolute alcohol in unresectable pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma [Phase 1]
Phase 1 trial evaluating nab-paclitaxel (Abraxane) in combination with gemcitabine and capecitabine (Xeloda) for pancreatic cancer has compl…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses
This entry provides an update on a completed clinical trial evaluating the use of contrast-enhanced endoscopic ultrasound for diagnosing pan…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating ARRY-334543 with gemcitabine in patients with advanced cancer, including pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]
This update reports Phase 2 results for using sorafenib in combination with erlotinib to treat unresectable pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating gemcitabine/oxaliplatin plus imatinib (Glivec) in gemcitabine-refractory pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer [Phase 3]
A phase 3 trial evaluating aflibercept added to gemcitabine versus placebo with gemcitabine in metastatic pancreatic cancer was terminated; …
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial comparing docetaxel plus gemcitabine versus docetaxel plus cisplatin in patients with metastatic or locally advance…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating glufosfamide with or without hydration in patients with advanced pancreatic cancer. The study has complete…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/3 trial comparing gemcitabine with radiation therapy versus gemcitabine alone in patients who have undergone surgery for pancreati…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine, cisplatin, and bevacizumab for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating gemcitabine with bevacizumab for pancreatic cancer that has been completely removed by surgery was ter…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating LE-DT for locally advanced or metastatic pancreatic cancer has completed, providing an efficacy and safety assessme…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy [Phase 3]
Phase 3 trial comparing pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy for pancreatic tumors has complet…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Prospective Study of Celiac Block Injection: 1 vs. 2 [Phase 4]
Phase 4 prospective trial comparing single versus dual celiac block injections in chronic pancreatitis and pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies [Phase 1]
Phase 1 safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed prior therapy has been completed, ev…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München [NA]
This ClinicalTrials.gov update notes the termination of a trial at Technische Universität München evaluating surgical resection for pancreat…